Login to Your Account



Capital Efficiency 'Under a Microscope'

Tough Economy Means No More Second Chances for Failed Firms

By Jennifer Boggs


Monday, April 20, 2009
"If at first you don't succeed, try, try again," has long been the motto of die-hard biotech investors, who have continued funneling cash into troubled firms - sometimes even in the wake of disastrous clinical results - hoping that the next trial, or the next product will be the success story.

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription